COVID-19 infection in patients with intestinal failure: UK experience

P J Allan1, T Ambrose1, C Mountford2

  • 1Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Insights

COVID-19 significantly impacted patients with intestinal failure (IF), particularly those requiring home parenteral nutrition (HPN). This study highlights infection rates and outcomes in IF patients during the pandemic.

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Public Health

Background:

  • The direct impact of the COVID-19 pandemic on patients with intestinal failure (IF) remains largely undescribed.
  • Patients with IF, especially those reliant on long-term parenteral nutrition, may represent a vulnerable population during infectious disease outbreaks.

Purpose of the Study:

  • To evaluate the infection rates, clinical presentations, and outcomes of COVID-19 in patients with types 2 and 3 intestinal failure.
  • To assess the specific risks and consequences for individuals dependent on home parenteral nutrition (HPN).

Main Methods:

  • A nationwide study was conducted across UK IF centers.
  • Data were collected on patients with types 2 and 3 IF who contracted COVID-19 between March and August 2020.
  • Infection rates were compared between HPN-dependent patients and hospitalized patients with type 2 IF.

Main Results:

  • A total of 45 patients with IF contracted COVID-19.
  • Infection rates were 1.2% for HPN-dependent adults and 6.4% for hospitalized type 2 IF adults.
  • The mortality rate directly attributed to COVID-19 was 6.7% among infected patients with types 2 or 3 IF.

Conclusions:

  • This is the first study to report on COVID-19 outcomes in a substantial cohort of patients requiring long-term parenteral nutrition.
  • Implementing strategies to minimize nosocomial transmission in both hospital and community settings is crucial for protecting this vulnerable patient group.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Intestinal Obstruction I: Introduction01:29

Intestinal Obstruction I: Introduction

Intestinal obstruction is a partial or complete blockage of the small or large intestine that disrupts the normal flow of intestinal contents through the lumen. This interruption impairs digestion, absorption, and fluid balance, and may lead to serious complications if not treated promptly.Mechanical ObstructionMechanical obstruction occurs when a physical blockage prevents intestinal contents from passing, arising from within the lumen or the bowel wall, or from external compression.Adhesions,...
Intestinal Obstruction II: Pathophysiology01:07

Intestinal Obstruction II: Pathophysiology

Intestinal obstruction triggers a series of physiological responses, starting with gas and fluid accumulation in the bowel segment proximal to the obstruction, leading to distension. This distended intestine compresses the diaphragm, hindering lung expansion and potentially leading to reduced respiratory effort, atelectasis, and pneumonia.To overcome the blockage, the gut intensifies contractions, causing colicky abdominal pain, nausea, and vomiting, which reduces fluid and food intake and...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...